Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-22.11% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
RKDA · Jun 30, 2026
Arcadia Biosciences, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 4[email protected]
Inspectable configuration
State dimensions
Filing0001193125-26-349205General Corporate
Evidence method
Yoy · gp.fundamentals.revenue
-0.82% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
64.45% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
43.73% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-34.37% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.00% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
0.97% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History19 statesSelf-history eligible
Dec 31, 20210/7 normalizedLevel 3Mar 31, 20220/7 normalizedLevel 3Jun 30, 20220/7 normalizedLevel 3Sep 30, 20220/8 normalizedLevel 3Dec 31, 20220/8 normalizedLevel 3Mar 31, 20230/8 normalizedLevel 3Jun 30, 20230/8 normalizedLevel 3Sep 30, 20236/8 normalizedLevel 3Dec 31, 20237/8 normalizedLevel 3Mar 31, 20247/8 normalizedLevel 3Jun 30, 20247/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20266/6 normalizedLevel 3Jun 30, 20267/7 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- -99.91%
- Current
- -22.11%
- Delta
- 77.80%
- Previous
- -8.33%
- Current
- -0.82%
- Delta
- 7.51%
- Previous
- 76.36%
- Current
- 64.45%
- Delta
- -11.91%
- Previous
- 36.36%
- Current
- 43.73%
- Delta
- 7.36%
- Previous
- -70.82%
- Current
- -34.37%
- Delta
- 36.45%
- Previous
- 1.36%
- Current
- 0.97%
- Delta
- -0.39%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
- Similarity
- 88%
- Compared
- 7 dimensions
- Coverage
- 100%
- Similarity
- 87%
- Compared
- 7 dimensions
- Coverage
- 100%
- Similarity
- 86%
- Compared
- 7 dimensions
- Coverage
- 100%
- Similarity
- 67%
- Compared
- 5 dimensions
- Coverage
- 71%
- Similarity
- 64%
- Compared
- 6 dimensions
- Coverage
- 86%
Research Graph
Related governed research
Analogous To · RKDA state analogue 1 →Analogous To · RKDA state analogue 3 →Analogous To · RKDA state analogue 2 →Analogous To · RKDA state analogue 4 →Analogous To · RKDA state analogue 5 →Compared To · Crude Petroleum & Natural Gas peers →Derived From · RKDA Company Quality Vector →Has State · Arcadia Biosciences, Inc. →Transitioned To · RKDA Fundamental State →Transitioned To · RKDA CASH_GENERATION_INCREASED →Transitioned To · RKDA GROWTH_INCREASED →Transitioned To · RKDA INVENTORY_PRESSURE_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.